HPS AFTER HOURS | EVENT #2
From Innovation to Patent
A crash course on IP strategy, legal pitfalls, and safeguarding your company’s innovations.
22 October 2026 | 15:00–17:30 | Herlev, Denmark
- Free to attend
- Registration required
- Limited availability
Does your patent portfolio match your current needs?
A robust IP structure is essential for protecting your innovations. As companies grow and partnerships expand across markets, patent requirements and legal frameworks can vary significantly. Inadequate protection can ulitmately put the foundations of your business at risk.
Herlev Pharma Service invites founders, management teams and business development professionals from small biotech and pharma companies to an informal afternoon session on patent portfolios and the associated legal implications.
The session will provide practical guidance on how to approach patent strategy, legal compliance and IP protection throughout a company’s lifecycle.
What we’ll discuss
Filing Strategy
Key considerations when preparing and submitting patent applications for strong, enforceable protection.
IP–Business Alignment
Structuring your patent portfolio to support company growth, partnerships, and commercial goals.</p
Future-Proofing
Building flexibility into your IP strategy so your portfolio stays relevant as science, markets, and regulations evolve.
Avoiding Pitfalls
Common mistakes in pharma patenting, from timing errors to claim-drafting issues, and how to avoid them.
Mikkel Bender
European Patent Attorney, Founding Partner at COPA Copenhagen Patents
Mikkel Bender is a patent attorney at Copenhagen Patents (COPA), advising life science companies on IP strategy, filing, and portfolio management.
He works with startups and established pharma companies alike, aligning patent protection with business goals.
At HPS After Hours, Mikkel will share practical insights on patent pitfalls and future-proofing your portfolio.
Jesper Lykkesfeldt
Attorney-at-Law, Founder of Lykkesfeldt
Jesper Lykkesfeldt is an attorney at Lykkesfeldt with 20 years of legal experience in life science.
Formerly Head of Legal at Genmab, he oversaw global R&D, licensing, M&A, partnerships, and dispute resolution.
At HPS After Hours, Jesper will address the legal nuances of patent law, as well as patent license agreements, and answer questions.
Bo Tandrup
CEO, Lophora
Bo Tandrup is CEO and co-founder of Lophora, a clinical-stage CNS biotech company.
Bo is a pharmaceutical executive and serial entrepreneur with over 15 years of experience. He previously founded Alkalon and has advised Goldman Sachs and McKinsey.
At HPS After Hours, Bo will share a real-world case from Lophora’s patent filing process.
15:00–15:15
Coffee and welcome
15:15–16:00
The Legal Aspects, by Mikkel Bender and Jesper Lykkesfeldt
16:00–16:30
Case Study: The Patent Filing Process at Lophora, by Bo Tandrup
16:30–17:30
Discussion and informal networking
Date
22 October 2026
Time
15:00–17:30
Location
Herlev Pharma Service
Herlev Hovedgade 195A, 1.tv.
2730 Herlev
Denmark
Participation
Free of charge. Registration is required.
Reserve your seat
We are keeping the event small and focused to allow time for questions, discussion and meaningful conversations.
Participation is free, but the number of seats is limited.